AI‐Based Platelet‐Independent Noninvasive Test for Liver Fibrosis in MASLD Patients
ABSTRACT Background and Aim Noninvasive tests (NITs), such as platelet‐based indices and ultrasound/MRI elastography, are widely used to assess liver fibrosis in metabolic dysfunction‐associated steatotic liver disease (MASLD). However, platelet counts are not routinely included in Japanese health c...
Saved in:
| Main Authors: | Shun‐ichi Wakabayashi, Takefumi Kimura, Nobuharu Tamaki, Takanobu Iwadare, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Naoki Tanaka, Masayuki Kurosaki, Takeji Umemura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | JGH Open |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jgh3.70150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug Pipeline for MASLD: What Can Be Learned from the Successful Story of Resmetirom
by: Elizabeta Knezović, et al.
Published: (2025-02-01) -
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes
by: Ankita Dua, et al.
Published: (2025-08-01) -
Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials
by: Hazem Ayesh, et al.
Published: (2024-10-01) -
C/EBPβ–VCAM1 axis in Kupffer cells promotes hepatic inflammation in MASLD
by: Shuang-Zhe Lin, et al.
Published: (2025-08-01) -
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
by: Jiatong Xu, et al.
Published: (2025-02-01)